Here is a link to the lawsuit below, half is black
Post# of 148325
Quote:
From June to December 2019 alone, Shkreli exchanged 240 emails with Mulleady and 391 emails with Mithani. In these communications, Shkreli continues to discuss strategies to prevent generic competition to Daraprim, as well as other matters of Vyera business strategy.
https://www.ftc.gov/system/files/documents/ca...dacted.pdf